Regenerative Medicine and Stem Cells Technologies

Lab-grown blood given to people in world-first clinical trial

• Nov 9 2022 - 15:45

Hearing loss gene therapy treatment given FDA rare pediatric disease designation

• Nov 9 2022 - 14:44

Developing gene therapies for neurodegenerative diseases: FDA finalizes guidance

• Nov 9 2022 - 14:22

Allogene starts first pivotal trials of an ‘off-the-shelf’ cell therapy for cancer

• Nov 9 2022 - 09:23

CAR-T pioneer Carl June on founding startups and cell therapy’s next act

• Nov 8 2022 - 12:17

How Human iPSCs are Revolutionizing Drug Discovery in 2022

• Nov 7 2022 - 09:17

Novartis’ Zolgensma Under Fire Again

• Nov 6 2022 - 13:53

Kite’s Yescarta First CAR T-cell Therapy to Receive European Marketing Authorization for Use in Second-Line Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma

• Nov 6 2022 - 13:51

New approach to immunotherapy provokes a robust anti-tumor immune response in preclinical models

• Nov 5 2022 - 11:24

Combined stem cell and gene therapy shows promise to treat patients with ALS

• Nov 2 2022 - 15:50